Related Experiment Videos
Cost-effective intervention in stroke
1Flinders Medical Centre, Bedford Park, Australia.
Insights
Effective stroke management is crucial due to its high mortality and disability rates. This review examines stroke epidemiology, costs, and the cost-effectiveness of prevention and rehabilitation strategies for better healthcare outcomes.
Area of Science:
- Neurology
- Public Health
- Health Economics
Background:
- Cerebrovascular disease, particularly stroke, is a leading cause of death and long-term disability globally.
- Stroke accounts for a significant portion of healthcare expenditure, with costs projected to rise due to an aging population.
- Optimizing stroke management is essential for minimizing healthcare costs and maximizing treatment effectiveness.
Purpose of the Study:
- To review the epidemiology of stroke, including risk factors, incidence, prevalence, and the burden of disability.
- To analyze community and individual costs associated with stroke.
- To evaluate the cost-effectiveness of various interventions for stroke prevention and rehabilitation.
Main Methods:
- Literature review of epidemiological studies on stroke.
- Analysis of economic evaluations of stroke care and interventions.
- Synthesis of evidence on the effectiveness and cost-effectiveness of preventive measures and rehabilitation.
Main Results:
- Stroke is the third leading cause of death and the primary cause of long-term disability in developed countries.
- Preventive strategies like hypertension control, smoking cessation, and healthy lifestyles show significant cost-effectiveness.
- Rehabilitation, though costly, can substantially reduce long-term disability and institutional care needs.
Conclusions:
- A comprehensive approach integrating prevention, acute care, and rehabilitation is vital for managing the burden of stroke.
- Further research into acute stroke treatments and long-term management strategies is warranted.
- Cost-effective interventions and rehabilitation programs are key to improving patient outcomes and reducing societal costs associated with stroke.
Abstract:
A rigorous assessment of current practice in all branches of medicine is necessary to ensure that we are minimising the costs and maximising the effectiveness of management and treatment. This is especially important in cerebrovascular disease which imposes a large burden of death; it is the third commonest cause of death after cancer and heart disease in most developed countries, and the commonest cause of long term disability on society. Stroke consumes up to 5% of healthcare expenditure in developed countries, and costs can be expected to remain static or increase with an increase in the proportion of elderly (who are at high risk of stroke) in the community over coming decades. This article reviews the epidemiology of stroke (risk factors, incidence, prevalence and the burden of disability and handicap), the various studies dealing with the community and individual costs of stroke, and the cost-effectiveness of interventions to prevent stroke such as control of hypertension, reduction in cigarette intake, encouragement of a healthy lifestyle, antiplatelet or anticoagulant therapy, and carotid endarterectomy. Acute treatment of stroke remains an area of major potential therapeutic benefit, but no widely applicable therapy currently exists, although many treatments are being investigated. Rehabilitation after stroke is costly, but may result in significant reduction in disability and handicap with reduced need for long term institutional care. The clinical implications of these studies and the potential for future research are also discussed.